Tag: Drug Discovery

Ukrainian and Danish Drug Discovery Alliance

Enamine Ltd. a provider of integrated drug discovery services empowered by the world’s largest collections of building blocks and screening compounds, and H. Lundbeck A/S (Lundbeck), the global pharma...

Exscientia Establishes Subsidiary for Expanding in Asia

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company announces the establishment of a subsidiary, Exscientia K.K to spearhead its pharmaceutical interests across As...

Ono Pharmaceutical and twoXAR in R&D Collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the c...

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

GM Chickens Produce Human Proteins

Genetically modified (GM) chickens could be used as a cheaper way to produce certain types of drugs compared to traditional manufacturing methods, research suggests. A team from The University of E...

Lupin Plans to Develop First-to-Market Products

Drug maker Lupin is in the process of developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders, a top company official sai...

Collaboration of Japanese Companies in AI Drug R&D

Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery. The companies are the latest to use AI and mac...